The study found that pretreatment CEA levels ≥10 ng/mL were a significant risk factor for overall survival (OS), distant metastases (DM), and local recurrence (LR) after PORT for cancer of the rectum (39). The gene discussed is CEACAM5; the disease is rectal cancer.